These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 15776276)

  • 1. The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin.
    Xenocostas A; Cheung WK; Farrell F; Zakszewski C; Kelley M; Lutynski A; Crump M; Lipton JH; Kiss TL; Lau CY; Messner HA
    Eur J Clin Pharmacol; 2005 May; 61(3):189-95. PubMed ID: 15776276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the pharmacokinetics of human recombinant erythropoietin in blood and brain when administered immediately after lateral fluid percussion brain injury and its pharmacodynamic effects on IL-1beta and MIP-2 in rats.
    Lieutaud T; Andrews PJ; Rhodes JK; Williamson R
    J Neurotrauma; 2008 Oct; 25(10):1179-85. PubMed ID: 18842103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetic profile of recombinant human erythropoietin is unchanged in patients undergoing cardiac surgery.
    McCluskey SA; Cheung WK; Katznelson R; Poonawala H; Fedorko L; Djaiani G; Mehta B; Karkouti K
    Eur J Clin Pharmacol; 2009 Mar; 65(3):273-9. PubMed ID: 18972109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of recombinant human erythropoietin in rabbits and 3/4 nephrectomized rats.
    Yoon WH; Park SJ; Kim IC; Lee MG
    Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):227-40. PubMed ID: 9226757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin in the cerebrospinal fluid of patients with aneurysmal subarachnoid haemorrhage originates from the brain.
    Springborg JB; Sonne B; Frederiksen HJ; Foldager N; Poulsgaard L; Klausen T; Jørgensen OS; Olsen NV
    Brain Res; 2003 Sep; 984(1-2):143-8. PubMed ID: 12932848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic, tolerability, and bioequivalence comparison of three different intravenous formulations of recombinant human erythropoietin in healthy Korean adult male volunteers: an open-label, randomized-sequence, three-treatment, three-way crossover study.
    Cho SH; Lim HS; Ghim JL; Choe S; Kim UJ; Jung JA; Bae KS
    Clin Ther; 2009 May; 31(5):1046-53. PubMed ID: 19539105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Pharmacokinetics of High-Affinity Transferrin Receptor Antibody-Erythropoietin Fusion Protein is a Function of Effector Attenuation in Mice.
    Sun J; Boado RJ; Pardridge WM; Sumbria RK
    Mol Pharm; 2019 Aug; 16(8):3534-3543. PubMed ID: 31199881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of lyophilized recombinant human erythropoietin-alpha following single-dose subcutaneous administration in premature newborns.
    Melo AM; Costa MT; Porta V; Vaz FA
    J Matern Fetal Neonatal Med; 2005 Jan; 17(1):55-8. PubMed ID: 15804788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacokinetics, safety, and tolerability after subcutaneous administration of recombinant human erythropoietin formulated with different stabilizers.
    Cheung WK; Natarajan J; Sanders M; Vercammen E
    Biopharm Drug Dispos; 2000 Sep; 21(6):211-9. PubMed ID: 11304719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of prolonged low doses of recombinant human erythropoietin during submaximal and maximal exercise.
    Russell G; Gore CJ; Ashenden MJ; Parisotto R; Hahn AG
    Eur J Appl Physiol; 2002 Mar; 86(5):442-9. PubMed ID: 11882931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics of recombinant human erythropoietin after intravenous and subcutaneous administration to healthy subjects.
    Salmonson T; Danielson BG; Wikström B
    Br J Clin Pharmacol; 1990 Jun; 29(6):709-13. PubMed ID: 2378790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of erythropoietin administration on cerebral metabolism and exercise capacity in men.
    Rasmussen P; Foged EM; Krogh-Madsen R; Nielsen J; Nielsen TR; Olsen NV; Petersen NC; Sørensen TA; Secher NH; Lundby C
    J Appl Physiol (1985); 2010 Aug; 109(2):476-83. PubMed ID: 20522733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin in the cerebrospinal fluid of neonates who sustained CNS injury.
    Juul SE; Stallings SA; Christensen RD
    Pediatr Res; 1999 Nov; 46(5):543-7. PubMed ID: 10541316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron supplementation enhances response to high doses of recombinant human erythropoietin in preterm infants.
    Carnielli VP; Da Riol R; Montini G
    Arch Dis Child Fetal Neonatal Ed; 1998 Jul; 79(1):F44-8. PubMed ID: 9797624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Macdougall IC; Roberts DE; Neubert P; Dharmasena AD; Coles GA; Williams JD
    Lancet; 1989 Feb; 1(8635):425-7. PubMed ID: 2563798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous pharmacokinetics/pharmacodynamics modeling of recombinant human erythropoietin upon multiple intravenous dosing in rats.
    Ait-Oudhia S; Scherrmann JM; Krzyzanski W
    J Pharmacol Exp Ther; 2010 Sep; 334(3):897-910. PubMed ID: 20501635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic studies on recombinant human erythropoietin.
    Salmonson T
    Scand J Urol Nephrol Suppl; 1990; 129():1-66. PubMed ID: 2255869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel method utilising markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes.
    Parisotto R; Gore CJ; Emslie KR; Ashenden MJ; Brugnara C; Howe C; Martin DT; Trout GJ; Hahn AG
    Haematologica; 2000 Jun; 85(6):564-72. PubMed ID: 10870111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin is present in the cerebrospinal fluid of neonates.
    Juul SE; Harcum J; Li Y; Christensen RD
    J Pediatr; 1997 Mar; 130(3):428-30. PubMed ID: 9063419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.